SARAH S KEHL

Allopathic & Osteopathic Physicians|Allergy & Immunology EUGENE, OR NPI 1992835367

General Payments — all program years on this page

$2,590.83

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 129
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $461.74 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $431.2918
Consulting Fee $30.451

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $167.1013
2019 $273.199
2020 $579.5141
2021 $322.898
2022 $255.4115
2023 $530.9924
2024 $461.7419

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087070568 Novartis Pharmaceuticals Corporation $24.90 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104202279 AstraZeneca Pharmaceuticals LP $38.88 07/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114084178 Regeneron Healthcare Solutions, Inc. $24.14 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115797125 Amgen Inc. $20.24 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116055319 GlaxoSmithKline, LLC. $28.13 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116564818 GlaxoSmithKline, LLC. $16.80 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116730540 GlaxoSmithKline, LLC. $15.40 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131616662 PFIZER INC. $24.35 12/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131660255 PFIZER INC. $28.52 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132152520 Pharming Healthcare, Inc. $19.08 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134611045 CSL Behring $30.15 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137597939 Takeda Pharmaceuticals U.S.A., Inc. $24.31 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137597942 Takeda Pharmaceuticals U.S.A., Inc. $18.12 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139737952 GENZYME CORPORATION $27.65 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139737978 GENZYME CORPORATION $13.50 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139738074 GENZYME CORPORATION $13.98 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147450148 Blueprint Medicines Corporation $16.16 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147450294 Blueprint Medicines Corporation $46.98 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149639652 ADMA BioManufacturing LLC $30.45 06/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.